MRD_Screening_Of_Human_B_ALL. MRD_Screening_Of_Human_B_ALL
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
MRD screening in Human B-ALL: monitoring B-cell repertoires in longitudinal samples of patients.
应用场景：
创建时间：
2015-09-04
相关数据集
Supplementary Material for: Monitoring minimal residual disease in RUNX1-mutated acute myeloid leukemia
Introduction: Mutated RUNX1 is considered a poor prognostic factor and usually is mutually exclusive with NPM1 mutations. Monitoring of molecular markers for minimal residual disease provides a powerf
Figshare2022-08-05 更新40
Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobulin gene rearrangements
IGH gene rearrangement and IGK-Kde gene deletion can be used as molecular markers for the assessment of B lineage acute lymphoblastic leukemia (B-ALL). Minimal residual disease detected based on those
Figshare2017-01-01 更新30
DataSheet_1_Patient specific real-time PCR in precision medicine – Validation of IG/TR based MRD assessment in lymphoid leukemia.pdf
Detection of patient- and tumor-specific clonally rearranged immune receptor genes using real-time quantitative (RQ)-PCR is an accepted method in the field of precision medicine for hematologic malign
NIAID Data Ecosystem10
Antibody repertoire sequencing of human tonsillar B cell subsets. Antibody repertoire sequencing of human tonsillar B cell subsets
In response to antigen challenge, human B cells clonally expand, undergo selection and differentiate within secondary lymphoid tissues to produce mature B cell subsets and high affinity antibodies nec
NIAID Data Ecosystem40
CLL stereotyped immunoglobulin gene rearrangement sequences in normal peripheral blood B cell subpopulations
Investigate the presence of CLL stereotyped immunoglobulins in healthy donor phenotypically distinct B cells subpopulations
NIAID Data Ecosystem20
